Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nvidia Corp (NVDA) vs Tempus AI (TEM) Price & Performance

Nvidia CorpTrade

Price performance (Past 24H)

Key statistics

Nvidia Corp vs Tempus AI — how do they compare? Nvidia Corp trades at $223.01 (market cap $5.45T), while Tempus AI trades at $60.98 (market cap $11.67B). The key difference: Nvidia Corp is far larger — about 467× Tempus AI's market cap, and Nvidia Corp pays a 0.44% dividend while Tempus AI pays none. Which is the better fit depends on your goals.

NVDATEM
Market Cap
$5.45T$11.67B
Sector
TechnologyBroad Market / Factor
52-Week High
$235.75$103.25
52-Week Low
$165.17$41.55
Enterprise Value
$5.43T$12.30B
Dividend Yield
0.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nvidia Corp

NVIDIA (NVDA) trades at $225.73, down 2.01% over the past day, amid a broader tech sell-off. The stock maintains a bullish technical signal with strong moving average support, while oscillators are neutral. Fundamentally, the company reported robust revenue of $130.50B in 2025, with net income surging to $72.88B, reflecting a 55.84% profit margin. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.22 surpassing the $2.09 estimate. Analyst sentiment remains overwhelmingly positive, with a consensus price target of $344.10 implying significant upside.

Outlook: NVDA's leadership in AI chips and accelerating revenue growth present a compelling investment case, though risks include heightened competition and potential market saturation. The stock's current valuation metrics, such as a P/E of 28.54, appear reasonable given its growth trajectory. Institutional ownership trends and strong cash flow generation support long-term bullish sentiment, but investors should monitor execution risks and macroeconomic headwinds.

Tempus AI

Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats despite negative profitability, with a P/S of 7.99 and P/B of 26.23. Recent catalysts include FDA clearance for an AI ECG product and a $9.5 million ARPA-H award for autonomous AI in cardiology (Business Wire, September 9, 2026).

Outlook remains positive given analyst consensus and growth in precision medicine, but risks include sustained losses, high valuation multiples, and cash burn. The consensus price target is $69.11, implying potential upside, though investors must weigh the company's unprofitability against its innovation pipeline and market position.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nvidia Corp

NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.

Read more on NVDA

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM